Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |
Ashwini*, Farheen, Triveni, Dr. Parameshwar Aleti, Dr. Karnakar Reddy Yalla
S.R.R. College of Pharmaceutical Sciences, Valbhapur (V), Elkathurthy (M), Hanumakonda (D), Telangana
A b s t r a c t
AIM: The Aim of the study was to compare the Effectiveness and Tolerance of Angiotensin II Receptor Blockers and Beta -Blockers in Cardiovascular Diseases. Objectives: To find out Adverse drug reactions in treatment. To evaluate drug-drug interactions. To find out further complications. To access adherence of medications. To find out the tolerance of medication chart to determine safe and effectiveness of patients. Methodology: A hospital-based comparative study was carried out for 6 months at single center Warangal, Telangana, India. patients were enrolled in the study based on treatment. Our study was used to study of effectiveness and tolerance in all cardiac patients all the relevant and necessary data was collected from patients, care takers, case sheets, prescriptions, and physicians. Results: A total of 190 patients diagnosed with various cardiovascular disease were recruited in the study, conducted in out patients of cardiology department. Conclusion: In this study, we observed that among 190 patients males are more prone to CVD’S than females. Mostly 51-60 years of age group are mostly affected to CVD. HTN subjects have high percentage compared to other CVD ‘s.Tolerance is more in beta blockers followed ARB’S. Betablockers are more effectiveness than ARB’S even though it has more tolerance. According to this study we can conclude that significantly increase risk for CVD’s in patients using ARB’S and betablockers. This findings was not altered by the inclusion of additional information of the ARB’s and beta blockers in the analysis. However due to the low power of the study, further studies are needed to reproduce our fin.
Keywords: betablockers., cardiovascular disease, CVD, ARB’S
